Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1994-11-08
1996-05-28
Jones, W. Gary
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
435 71, 4351723, 4353201, 530350, C07H 2100, C12N 1506, C12N 510, C07K 1400
Patent
active
055212956
ABSTRACT:
Provided are hybrid receptor molecules wherein one domain of the receptor is derived from the cytokine superfamily of receptors and other domain is derived from a heterologous family of receptors. Also provided are methods for identifying ligands that bind to the hybrid receptor molecules.
REFERENCES:
patent: 4859609 (1989-08-01), Dull et al.
patent: 5030576 (1991-07-01), Dull et al.
Seedorf et al., "Analysis of Platelet-derived Growth Factor Receptor Domain Function Using a Novel Chimeric Receptor Approach*," The Journal of Biological Chemistry, vol. 266, 12424-12431, Jan. 1991.
Venkitaraman and Cowling, Interleukin 7 receptor functions by recruiting the tyrosine kinase etc., Proc. Natl. Acad. Sci. USA vol. 89, 12083-12087, Dec. 1992.
Yan et al., Chimeric NGF-EGF Receptors Define Domains Responsible for Neuronal Differentiation, Science, vol. 252, 561-563 Apr. 1991.
Zon et al., The Erthropoietin Receptor Transmembrane Region etc., Molecular and Cellular Biology, vol. 12, No. 7, 2949-2957 Jul. 1992.
Adachi et al., Identification of a domain of ET.sub.A receptor required for ligand binding, FEBS Letters, vol. 311, No. 2, 179-183, 1992.
Bernard et al., High-affinity interleukin 2 binding by an oncogenic hybrid interleukin 2-epidermal growth factor receptor molecule, Proc. Natl. Acad. Sco. USA, vol. 84, 2125-2129, Apr. 1987.
Fuh et al., Rational Design of Potent Antagonists to the Human Growth Hormone Receptor, Science, vol. 256, 1677-1680, Jun. 1992.
Koller et al., Conservation of the Kinaselike Regulatory Domain etc., Molecular and Cellular Biology, vol. 12, No. 6, 2581-2590 Jun. 1992.
Lev et al., Receptor Functions and Ligand-Dependent Transforming Potential of a Chimeric etc., Molecular and Cellular Biology, vol. 10, No. 11, 6064-6068, Nov. 1990.
Luyten and Leysen, Receptor cloning and heterologous expression-towards a new tool for drug discovery, TIBTECH reviews vol. 11, 247-254, Jun. 1993.
Ohashi et al., Ligand-induced activation of chimeric receptors between the erythoropoietin receptor and receptor tyrosine kinases, Proc. Nat'l Acad. Sci. USA, vol. 91, pp. 158-162, Jan. 1994.
Pacifici et al., Hybrid Tyrosine Kinase/Cytokine Receptors Transmit Mitogenic Signals in Response to Ligand, Journal of Biological Chemistry, vol. 269, No. 3, Issue of Jan. 21, 1994, pp. 1571-1574.
Maruyama et al., Proliferation and Erythroid Differentiation through the Cytoplasmic Domain of the Erythropoietin Receptor, Journal of Biological Chemistry, vol. 269, No. 8, Issue of Feb. 25, 1994, pp. 5976-5980.
Riedel et al., A Chimaeric Receptor Allows Insulin to Stimulate Tyrosine Kinase Activity of Epidermal Growth Factor Receptor, NATURE, vol. 324, 6 Nov. 1986, pp. 68-70.
Pacifici Robert E.
Thomason Arlen R.
Amgen Inc.
Jones W. Gary
Oleski Nancy
Schreiber David
LandOfFree
Nucleic acids encoding hybrid receptor molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids encoding hybrid receptor molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding hybrid receptor molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-788043